Renflexis

Product NDC
78206-162
11-digit product format
782060162
Labeler code
78206
Product ID
78206-162_ae5aa866-45c5-4dd8-ace4-cabe72994604
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
infliximab
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Labeler
Organon LLC
Application
BLA761054
Marketing category
BLA
Marketing start
2017-04-21
Substance
INFLIXIMAB
Active strength
100 mg/1
Pharmacologic classes
Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Renflexis
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
INFLIXIMAB100 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
UniiB72HH48FLU
Rxcui1927285, 1927290

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
fd7a994a-5706-4fb6-ad0f-bf950de5c161Product name120250721
726062af-1135-4707-a1d7-57256991bbf9Product name220250226
6e0fa83e-7840-4808-ae8f-3478d418847bProduct name120230703
19c71a3d-ed9c-166b-a7e5-38c250c35631Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
78206-162-01Renflexis1 in 1 CARTONINJECTION, POWDER, LYOPHILIZED,16
78206-162-99Renflexis1 in 1 VIALINJECTION, POWDER, LYOPHILIZED,16

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
78206-162-01EA - Each78206-162fb7866b4-f67e-49d1-8341-cba0bf1d1dfd12021-10-08
78206-162-99EA - Each78206-162f9747780-44d4-48f9-9153-774589e1889c12021-10-08

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
78206-162RENFLEXIS (INFLIXIMAB) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ORGANON LLC]3Current NDC, Legacy NDC, 2 package rows20240110_dbf738c4-3fac-4422-a9d8-51d9c83a8789.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1927285inFLIXimab-abda 100 MG InjectionPSNdbf738c4-3fac-4422-a9d8-51d9c83a87896
1927290RENFLEXIS 100 MG InjectionPSNdbf738c4-3fac-4422-a9d8-51d9c83a87896
1927290infliximab-abda 100 MG Injection [Renflexis]SBDdbf738c4-3fac-4422-a9d8-51d9c83a87896
1927285infliximab-abda 100 MG InjectionSCDdbf738c4-3fac-4422-a9d8-51d9c83a87896
1927290Renflexis 100 MG InjectionSYdbf738c4-3fac-4422-a9d8-51d9c83a87896

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
78206-162-01782060162011 VIAL in 1 CARTON (78206-162-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (78206-162-99) 1 vial2021-06-010000-00-00NoNoCurrent
78206-162-99782060162991 in 1 VIALHistorical